Abiopharma

News list

Director EVERITT DAVID C 🟢 acquired 740 shares of BRUNSWICK CORP (BC) at $79.00 Transaction Date: Jul 31, 2026 | Filing ID: 000103

Full text

News bot Aug. 3, 2026, 10:19 p.m.
🔍 EVERITT DAVID C (Director)

Company: BRUNSWICK CORP (BC)

Report Date: 2026-07-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 740
Detailed Transactions and Holdings:
- Acquired 740 shares of Common Stock at $79.0 per share (Direct)
  Date: 2026-07-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 39,908.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
- F2: Beneficial holdings include 203 shares acquired pursuant to dividend reinvestments through June 2026.